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and confocal images of an oval, sharply marginated, erythematous
psoriatic lesion, 9 mm in diameter located on the outer forearm.
The images show lesional (involved) skin at the dermo–epidermal
level, the border of the lesion, and immediately adjacent normal
(uninvolved) skin. Papillomatosis (increased number and size of
dermal papillae) is one major histologic feature of psoriasis; this was
easily visualized in the confocal images. A series of frames from
confocal images of the dermo–epidermal junction showing the
transitional margin of a psoriatic lesion is presented in Fig 2.
This study suggests that potential applications of confocal reflectance
microscopy include precise real-time detection of lesion margins
in vivo. This may eventually lead to confocal imaging-guided
surgeries including biopsies and Mohs’ micrographic surgery.
Salvador Gonza´lez,* Milind Rajadhyaksha,*† and
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Somatic Mutations of the MEN1 Tumor Suppressor Gene
Detected in Sporadic Angiofibromas
To the Editor:
Angiofibromas are benign cutaneous tumors that can occur sporadically
or as multiple lesions in association with inherited diseases. Multiple
facial angiofibromas were previously thought to be pathognomonic for
tuberous sclerosis (Darling et al, 1997); however, it has recently
been shown that angiofibromas may also be associated with multiple
endocrine neoplasia type I (MEN1) (Darling et al, 1997). The genetic
changes leading to the development of angiofibromas are unknown.
The MEN1 gene has been recently mapped (Larsson et al, 1988) and
identified (Chandrasekharappa et al, 1997). Tumors in MEN1 disease,
including benign tumors of the parathyroid glands, pituitary glands,
and pancreas, show genetic alterations of the MEN1 gene and the
association of cutaneous angiofibromas with MEN1 disease was recently
confirmed by genetic analysis (Pack et al, 1998). Because MEN1 gene
alterations are involved in MEN1-associated angiofibromas, we decided
to investigate whether MEN1 gene alterations can also be detected in
sporadic angiofibromas. For this purpose, we analyzed 19 sporadic
facial angiofibromas (Fig 1) for mutations in the MEN1 gene using
polymerase chain reaction based SSCP and sequencing analysis. All
patients had a negative family history for tuberous sclerosis and
MEN1 disease.
Tumor tissue and adjacent normal control tissue was removed from
histologic sections under light microscopic visualization, placed in
DNA extraction buffer (50 mmol Tris-HCL per liter, 1 mmol
ethylendiamine tetraacetate per liter, 0.5% Tween-20, and 0.5 mg
proteinase K per ml, pH 8.0), and incubated overnight at 37°C,
followed by thermal inactivation of proteinase K (95°C for 5 min).
Polymerase chain reaction/SSCP analysis was performed using 13
primer sets with designed intronic sequences to amplify the coding
sequence of exons 2–10 of the MEN1 gene as previously described.
Aberrant bands were identified in two of the 19 analyzed angiofibromas
involving exons 2 (pt#3) and 8 (pt#5). The DNA from these two
tumors was subjected to sequencing analysis.
Aberrant bands were detected in two tumors (Fig 2). The mutations
consisted of a A→T transition at nucleotide 517 (AAG to TAG; K135I)
and a transversion of GG→AA at nucleotide 1184–5 (GAG GAG to
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Figure 1. Cutaneous angiofibroma (case 3) with dermal fibrosis and
prominent vascular architecture. Scale bar: 100 µm.
GAA AAG; E358E; E359K) on exons 2 and 8, respectively (Fig 2).
The mutations were only observed in the tumor DNA, but not in
the normal control tissue. LOH analysis was performed using two
polymorphic markers flanking the gene on both sides (PYGM,
D11S449, Research Genetics, Huntsville, AL). None of the 19 angiofi-
bromas showed LOH, including the two sections displaying mutations.
Angiofibromas consist of at least two different types of proliferating
cells, which have been referred to as vascular cells and spindle-shaped,
triangular, or stellate cells of unknown origin (Lever and Schaumburg-
Lever, 1990) (Fig 1). Therefore, angiofibromas may in fact consist of
a mixed population of neoplastic and non-neoplastic cells, and LOH
results may be obscured by ‘‘contamination’’ with normal somatic cells.
Somatic cell ‘‘contamination’’ can be observed in our SSCP analysis in
the two cases with mutations, which show marked wild-type bands
and less intense aberrant bands (Fig 2). Similarly, ‘‘contamination’’
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Figure 2. SSCP and sequencing analysis of angiofibromas (case 3, left;
case 5, right). Both cases show aberrant bands on the SSCP gels (arrows; T,
tumor tissue; N, normal control tissue). In addition to the aberrant bands,
strong wild-type bands are present in both tumors. Sequencing analysis shows
a A→T transition at nucleotide 517 (AAG to TAG; case 3) and a transversion
of GG→AA at nucleotide 1184–5 (GAG GAG to GAA AAG; case 5), on
exons 2 and 8.
with normal somatic cells was implicated for the negative results in a
recent study that failed to detect LOH in three angiofibromas from
MEN1 patients (Dong et al, 1997).
Erythropoietic Protoporphyria: A New Mutation Responsible
for Exon Skipping in the Human Ferrochelatase Gene
To the Editor:
Erythropoietic protoporphyria is an inherited disorder associated with
intense light sensitivity caused by the diminished activity of the enzyme
ferrochelatase. It catalyzes the last step in haem biosynthesis by inserting
ferrous ion into protoporphyrin IX. A reduction in enzyme activity
of 30%–50% in different tissues is characteristic in patients and produces
an accumulation of protoporphyrin IX in erythrocytes, serum, liver,
and feces followed by lethal obstructive hepatic failure in some cases
(Todd, 1994). The ferrochelatase gene was cloned and localized to
chromosome 18q 21.3. Since then several mutations have been
published with different forms of transmission, demonstrating the
heterogeneity of the molecular pathology responsible for erythropoietic
protoporphyria. Discovering new mutations and correlating these with
the biochemical data may help in predicting the clinical course of the
disease and would allow intervention to combat any possibly lethal
consequences.
A blood sample was taken from a 35 y old man who has been
suffering from burning sensations, pain, and iching since his early
childhood, and from time to time the occurrence of small vesicles after
exposure to sun light. His parents are symptomless and there is no
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The identification of distinct somatic MEN1 mutations in sporadic
(non-MEN1 associated) angiofibroma suggests a role for the MEN1
gene product not only in MEN1 patients, but also in the initiation
and/or progression of a subset of sporadic angiofibromas.
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history of photosensitivity in other family members. Physical examina-
tion revealed orange peel-like skin on his forehead, nose, and hands
and his red blood cells showed red fluorescence under UVA illumination
due to raised protoporphyrin levels. Its concentration in erythrocyte
was 432 µg per 100 ml RBC and ferrochelatase activity in periferal
lymphocytes was decreased to 35% of normal levels (Nunn et al, 1988).
He has taken beta-carotene with slight benefical effects.
Peripheral blood samples from the probands’ father, mother, sister,
and 11 y old daughter were also collected and the lymphocytes isolated.
Total RNA and DNA were extracted from them and complementary
DNA synthetized by reverse transcriptase polymerase chain reaction
using the forward primer, p1 (59-GAGGCTGCCCAGGCAA-39;
Nakahashi et al 1993) and the reverse primer, p2 (59 -TTTTCAACT-
CCACACTCC-39). The latter was designed with the help of the
GCG computer program and allows amplification of most of the amino
acid coding region (1105 bp). After purifying the polymerase chain
reaction product, chemical cleavage of mismatch analysis was carried
out to identify the site of the deletion. Asymmetric polymerase chain
reactions were subsequently carried out and chain termination DNA
sequencing was performed to characterize the mutation. The boundaries
of exon 2 were amplified with primer sets 3 (Wang et al, 1994) using
genomic DNA as the template.
The proband’s amplified cDNA was found to be µ100 bp shorter
than that from the control (Fig 1A, II.2). Polymerase chain reactions,
using nested primers, showed that the site of the deletion was near the
59-end of the cDNA (data not shown). Direct sequencing of the
cDNA using the p1 forward primer subsequently revealed that exon
2 (127 bp) was missing (Fig 1B). The boundaries of exon 2 in the
